 
| Content-Type: |
text/plain; charset="iso-8859-1" |
| Sender: |
|
| Subject: |
|
| From: |
|
| Date: |
Mon, 14 Apr 2003 10:33:29 -0400 |
| MIME-Version: |
1.0 |
| Comments: |
|
| Reply-To: |
|
| Parts/Attachments: |
|
|
Infant levels as high as 9% of maternal levels. Metabolite present in low
but detectable concentrations in infants. No adverse effects notes, but
monitor for agitation, insomnia, and poor feeding. Use alternative SSRI if
possible.
Ilett KF, Hackett LP, Dusci LJ, et al. Distribution and excretion of
venlafaxine and o-desmethylvenlafaxine in human milk. Br J Clin Pharmacol
1998; 45: 459-62.
Ilett KF, Kristensen JH, Hackett LP, et al. Distribution of venlafaxine
o-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 2002; 53: 17-22.
Frank J. Nice, DPA, CPHP
***********************************************
To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html
|
|
|
